Archive

Initiating the provision of analysis information on differences in drug effects for each genetic polymorphism for contributing to the advancement of drug development and improvement in treatment options and treatment satisfaction for patients. 3H Medi Solution Inc. (Toshima-ku, Tokyo; CEO: Hirotaka Takizawa) and Genequest Inc. (Minato-ku, Tokyo; CEO: Osamu Iwata) have jointly conducted an analysis […]

The world is transitioning into the information age in healthcare and modern digital health technologies have a lot to offer in optimising clinical trial conduct. The advent of wearable medical devices has enabled collection of multi-dimensional subject data. This has enabled de-centralisation of clinical trial conduct. 3H has been agile to adopt the latest information […]

Clinical trial conduct is a substantial investment requiring the right mix of resources and time. With the pharmaceutical industry facing many challenges in the Western world due to escalating costs and challenges in meeting the recruitment and retention of subjects, there is a trend in navigating clinical trial options in the Asian continent. Contract research […]

Supporting clinical trial patients at home is getting popular choice today in Japan following this pandemic. The need for decentralized clinical trials in Japan has increased, as measures have been implemented to prevent the re-emergence of the outbreak and streamline the systems used to run clinical trials. Unless mandatory, clinical trial patients are served in […]

Background: Adaptive clinical trials bring in flexibility, efficiency and improves the satisfaction levels of clinical trial subjects. This ulcerative colitis study by 3H has been executed to enhance patient centricity. Ulcerative colitis, a rather less common medical condition has had limited clinical trials performed in the past. However, novel therapy is opening doors for improved treatment. […]

LOS ANGELES and TOKYO, October  27, 2021 — Science 37,  the Operating System for today’s more agile clinical trials and 3H Medi Solution Inc., a clinical trials solution leader in Japan today announced a collaboration to further decentralized clinical trials and accelerate the development of therapies. In this partnership, 3H Medi Solution will use Science […]

Non-small cell lung cancer (NSCLC), which is a type of epithelial lung cancer is prevalent in Japan. The absolute number of newly reported cases and deaths in men and women have increased over the years. Building awareness about the trial is an important strategy for recruitment. It is important that not just patients with NSCLC […]

A recent study conducted to estimate the prevalence of depression among adolescents has shown that there is high prevalence. Results indicate that there is a 10% young population with depression which amounted to approximately 550,000 adolescents. These children were treated by psychiatrists using pharmacotherapy and indicates a growing need for having approved treatments in adolescents […]

South Korea has made a name in the clinical trial industry through its unprecedented growth in the industry during the past two decades. There has been several regulatory reforms, adoption of ICH-GCP and continuous investment by the government to enhance the standards and quality of clinical trial conduct to make the country a Global Centre […]

Medical care is undergoing rapid changes and the latest technology has provided solutions for the growing complex problems in aging care and other healthcare needs. With the pandemic taking a toll, it has added innovative care delivery methods for the nursing of patients from the comfort of homes moving beyond the traditional hospital beds where […]